000952 廣濟藥業
按盤價 
6.720 -0.010 (-0.149%)
6.720 -0.010 (-0.149%) | 2025/09 - 九個月 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | -9.584 | -24.320 | -9.787 | 3.395 | 7.766 |
| 總資產報酬率 ROA (%) | -3.621 | -10.142 | -5.100 | 2.228 | 5.467 |
| 投入資產回報率 ROIC (%) | -3.990 | -11.454 | -5.754 | 2.467 | 6.066 | 邊際利潤分析 |
| 銷售毛利率 (%) | 29.397 | 18.738 | 27.405 | 36.998 | 38.347 |
| 營業利潤率 (%) | -24.463 | -49.764 | -19.118 | 7.620 | 15.046 |
| 息稅前利潤/營業總收入 (%) | -16.623 | -41.376 | -13.133 | 9.440 | 17.838 |
| 淨利潤/營業總收入 (%) | -24.933 | -49.332 | -20.657 | 5.978 | 13.469 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 115.078 | 84.835 | 88.747 | 79.031 | 64.450 |
| 價值變動淨收益/利潤總額(%) | -17.572 | 8.717 | 7.126 | 10.490 | 15.058 |
| 營業外收支淨額/利潤總額(%) | 1.845 | 0.749 | -0.275 | -1.163 | 4.939 | 償債能力分析 |
| 流動比率 (X) | 0.671 | 0.993 | 1.253 | 1.537 | 1.312 |
| 速動比率 (X) | 0.412 | 0.646 | 0.907 | 1.199 | 1.007 |
| 資產負債率 (%) | 62.671 | 61.476 | 54.037 | 39.602 | 29.191 |
| 帶息債務/全部投入資本 (%) | 54.096 | 41.884 | 34.994 | 29.155 | 19.602 |
| 股東權益/帶息債務 (%) | 75.541 | 101.135 | 147.478 | 230.828 | 403.704 |
| 股東權益/負債合計 (%) | 59.700 | 62.009 | 83.286 | 153.619 | 244.523 |
| 利息保障倍數 (X) | -2.003 | -4.721 | -2.214 | 4.949 | 8.876 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 100.361 | 108.142 | 100.441 | 86.866 | 65.786 |
| 存貨周轉天數 (天) | 284.803 | 215.341 | 174.906 | 138.366 | 122.049 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 28/10/2025 11:47 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
